CHET3

CAS No. 2489231-47-0

CHET3( —— )

Catalog No. M36427 CAS No. 2489231-47-0

CHET3 is a highly selective allosteric activator for TASK-3-containing K2P channels. CHET3 has shown potent in vivo analgesic effects in various acute and chronic pain models in rodents.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 296 In Stock
10MG 429 In Stock
25MG 661 In Stock
50MG 876 In Stock
100MG 1181 In Stock
200MG 1572 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CHET3
  • Note
    Research use only, not for human use.
  • Brief Description
    CHET3 is a highly selective allosteric activator for TASK-3-containing K2P channels. CHET3 has shown potent in vivo analgesic effects in various acute and chronic pain models in rodents.
  • Description
    CHET3 is a highly selective allosteric activator for TASK-3-containing K2P channels. CHET3 has shown potent in vivo analgesic effects in various acute and chronic pain models in rodents.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Potassium Channel
  • Recptor
    Potassium Channel
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2489231-47-0
  • Formula Weight
    423.49
  • Molecular Formula
    C21H21N5O3S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N(C(NC=1NC(CSC2=CC=C(C)C=C2)=CC(=O)N1)=N)C=3C=C4C(=CC3)OCCO4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • GAL-021

    A novel respiratory stimulant that acts as a potent calcium-activated potassium (BKCa) channel blocker blocker.

  • OR-1896

    OR-1896 is the active metabolite of Levosimendan, a highly specific phosphodiesterase (PDE III) inhibitor, a vasodilator with partial anti-inflammatory properties that produces vasodilation in different types of blood vessels through activation of ATP-sensitive (KATP) and other potassium channels.

  • BMS-191011

    BMS-191011 is an activator of large-conductance calcium-activated potassium (BKCa) channels effective in stroke models.